{
    "2019-08-20": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Bayer Sells Animal Health Division to Elanco: Now What?",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Animal Health",
                        "Elanco",
                        "sale"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "IXJ, LLY, ABBV, DHR: Large Outflows Detected at ETF",
                "features": {
                    "keywords": [
                        "IXJ",
                        "LLY",
                        "ABBV",
                        "DHR",
                        "ETF",
                        "outflows"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Here's Why Allergan is Outperforming Its Industry Of Late",
                "features": {
                    "keywords": [
                        "Allergan",
                        "outperforming",
                        "industry"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "The Time is Right For This Dividend ETF",
                "features": {
                    "keywords": [
                        "dividend",
                        "ETF",
                        "right time"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Buy AbbVie Stock Because You ‘Can’t Ignore’ How Cheap It Is",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "buy",
                        "cheap"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA",
                        "approval",
                        "immunology",
                        "Humira"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "High-Dividend Stocks on Historic Discount as Yields Plunge, says Goldman",
                "features": {
                    "keywords": [
                        "high-dividend",
                        "stocks",
                        "historic discount",
                        "yields",
                        "Goldman"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}